Buffington Mohr Mc Neal Abbott Laboratories Transaction History
Buffington Mohr Mc Neal
- $569 Million
- Q2 2024
A detailed history of Buffington Mohr Mc Neal transactions in Abbott Laboratories stock. As of the latest transaction made, Buffington Mohr Mc Neal holds 79,516 shares of ABT stock, worth $8.92 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
79,516
Previous 93,234
14.71%
Holding current value
$8.92 Million
Previous $10.6 Million
22.03%
% of portfolio
1.45%
Previous 1.92%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,138Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.35 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.06 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.42 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...